Panel

additional panel hereditary breast cancer (PALB2, CHEK2, ATM)

Turnaround time
3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 520

additional panel hereditary breast cancer (PALB2, CHEK2, ATM)



€ 520

additional panel hereditary breast cancer (PALB2, CHEK2, ATM)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 520
Panel

additional panel hereditary ovarian cancer (BRIP1, RAD51C, RAD51D)

Turnaround time
3 weeks
Performing laboratory
Radboudumc
€ 520

additional panel hereditary ovarian cancer (BRIP1, RAD51C, RAD51D)



€ 520

additional panel hereditary ovarian cancer (BRIP1, RAD51C, RAD51D)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 520
Panel

panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)

Turnaround time
3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 520

panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)



€ 520

panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 520
Panel

panel hereditary ovarian cancer (BRCA1, BRCA2, BRIP1, RAD51C, RAD51D)

Turnaround time
3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 520

panel hereditary ovarian cancer (BRCA1, BRCA2, BRIP1, RAD51C, RAD51D)



€ 520

panel hereditary ovarian cancer (BRCA1, BRCA2, BRIP1, RAD51C, RAD51D)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 520
Gene

ATM - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 509

ATM - risk factor breast cancer



€ 509

ATM - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • additional panel hereditary breast cancer (PALB2, CHEK2, ATM)
  • panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)
  • WES hereditary cancer (97.2% **)
  • WES Mendelian inherited disorders (97.2% **)
  • WES movement disorders (97.2% **)
  • WES primary immunodeficiencies (97.2% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 607585
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 320

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)



€ 320

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)
  • panel hereditary ovarian cancer (BRCA1, BRCA2, BRIP1, RAD51C, RAD51D)
  • WES hereditary cancer (98.1% **)
  • WES Mendelian inherited disorders (98.1% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries
Remarks
Analysis of a known familial mutation only (screening).

OMIM: 113705
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 320
Gene

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 320

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)



€ 320

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)
  • panel hereditary ovarian cancer (BRCA1, BRCA2, BRIP1, RAD51C, RAD51D)
  • WES hereditary cancer (98.7% **)
  • WES Mendelian inherited disorders (98.7% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries
Remarks
Analysis of a known familial mutation only (screening).

OMIM: 600185
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 320
Gene

BRIP1 - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 509

BRIP1 - hereditary ovarian cancer (only familial mutation testing)



€ 509

BRIP1 - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 605882
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

CHEK2 - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

CHEK2 - risk factor breast cancer



€ 509

CHEK2 - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • additional panel hereditary breast cancer (PALB2, CHEK2, ATM)
  • panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)
  • WES hereditary cancer (80.1% **)
  • WES Mendelian inherited disorders (80.1% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 604373
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

PALB2 - hereditary breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

PALB2 - hereditary breast cancer



€ 509

PALB2 - hereditary breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • additional panel hereditary breast cancer (PALB2, CHEK2, ATM)
  • panel hereditary breast cancer (BRCA1, BRCA2, PALB2, CHEK2, ATM)
  • WES hereditary cancer (99.9% **)
  • WES Mendelian inherited disorders (99.9% **)
  • WES skin disorders* (99.9% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 610355
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

RAD51C - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 509

RAD51C - hereditary ovarian cancer (only familial mutation testing)



€ 509

RAD51C - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 613399
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

RAD51D - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 509

RAD51D - hereditary ovarian cancer (only familial mutation testing)



€ 509

RAD51D - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 614291
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509